Please login to the form below

Not currently logged in
Email:
Password:

ShangPharma hires Biogen exec

Art Taveras joins as chief scientific officer 

ShangPharma, Art Taveras ShangPharma has hired Biogen Idec's Dr Art Taveras as president and chief scientific officer.

Dr Taveras held several vice president roles at US-based biotech Biogen, including for small molecules drug discovery, chemistry R&D and CMC development.

He now moves to China to head science at ShangPharma, a clinical research organisation (CRO) which employs 2,000 scientists.

"His extensive leadership, strategic and technical experience at the highest levels in pharmaceutical drug discovery and development will be a great asset to the company as it strives to become the preferred small molecules and biologics drug discovery partner for biopharmaceutical companies,” said Michael Hui, chairman and CEO of ShangPharma.

Dr Taveras' career prior to joining Biogen includes senior positions at Alantos Pharmaceuticals and Schering-Plough.

28th October 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

The big dilemma in international digital pharma marketing
How to get consistent international marketing while meeting local affiliates’ needs....
Why pharma content marketing campaigns should be agile
Agile pharma content marketing is simply about responding to customer needs, rather than your own whims....
Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...

Infographics